0001474064-11-000058.txt : 20111110 0001474064-11-000058.hdr.sgml : 20111110 20111110115330 ACCESSION NUMBER: 0001474064-11-000058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111109 FILED AS OF DATE: 20111110 DATE AS OF CHANGE: 20111110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BESHAR LUKE M CENTRAL INDEX KEY: 0001192128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 111193945 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE STREET 2: 3RD FLOOR CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 edgar.xml PRIMARY DOCUMENT X0304 4 2011-11-09 0000890465 NPS PHARMACEUTICALS INC NPSP 0001192128 BESHAR LUKE M 550 HILLS DRIVE BEDMINSTER NJ 07921 0 1 0 0 SVP & CFO Common Stock 2011-11-09 4 P 0 20000 5.36 A 22639 D Represents the purchase of 20,000 shares in 14 separate transactions, ranging from $5.32 to $5.37 per share, resulting in a weighted average purchase price per share of $5.3572. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range. Includes 2,639 shares of stock obtained through the Issuer's Employee Stock Purchase Plan. /s/ Luke Beshar, by Edward Stratemeier as attorney-in-fact 2011-11-10